FCI
MA - PembrokeBiotechnology
Focus: FCI is a medical device biotech company focused on punctal occlusion devices, a specialized niche within ophthalmology addressing dry eye disease and related conditions. Founded in 2021 and headquartered in Pembroke, MA, the company is in early-stage development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About FCI
AI assessmentNot HiringNo open roles listed right now. Follow FCI to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Twicare® appliance
Malocclusion, Angle Class II, Division 1Clinical Trials (1)
NCT02428621Early Treatment for Class II Division 1 Malocclusion With Twicare® and Herbst Removable Appliances
N/AHelp build intelligence for FCI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.